Search for Clinical Trial Results

Sponsored By

Paraneoplastic Syndromes - 51 Studies Found

Status Study
Completed Study Name: Immunotherapy of the Paraneoplastic Syndromes
Condition: Paraneoplastic Syndromes
Date: 2006-09-18
Interventions: Drug: Tacrolimus Tacrolimus at doses of 0.15- 0.3mg/kg/day in two divided oral doses, in conjunction wit
Completed Study Name: Studies of Neurological Paraneoplastic Syndromes
Condition: Paraneoplastic Neurologic Degenerations (PNDs)
Date: 2007-12-21
Recruiting Study Name: The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes
Condition: Paraneoplastic Syndromes
Date: 2006-05-17
Completed Study Name: One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Condition:
  • Osteoporosis
  • Humoral Hypercalcemia of Malignancy
  • Hyperpara
    Date: 2007-12-20
    Interventions: Drug: PTHrP (1-36) IND # 49,175 Other Name: Parathyr
Completed Study Name: Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
Condition:
  • Breast Cancer
  • Hypercalcemia of Malignancy
  • Metastatic Cance
    Date: 2007-04-09
    Interventions:
    • Drug: zoledronic acid
    • Procedure: quality-o
Completed Study Name: Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Condition:
  • Breast Cancer
  • Hypercalcemia of Malignancy
  • Metastatic Cance
    Date: 2006-05-16
    Interventions:
    • Drug: ibandronate sodium
    • Drug: zoledronic

Withdrawn Study Name: S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
Condition:
  • Breast Cancer
  • Hypercalcemia of Malignancy
  • Metastatic Cance
    Date: 2006-03-09
    Interventions:
    • Drug: ibandronate Other Name:

Completed Study Name: Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
Condition:
  • Breast Cancer
  • Hypercalcemia of Malignancy
  • Metastatic Cance
    Date: 2003-05-06
    Interventions:
    • Biological: monoclonal antibody CAL
    • Drug:

Completed Study Name: Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
Condition:
  • Hypercalcemia of Malignancy
  • Lung Cancer
  • Metastatic Cancer<
    Date: 1999-11-01
    Interventions:
    • Drug: zoledronic acid
    • Procedure: quality-o
Active, not recruiting Study Name: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China
Condition: Anti-NMDA Receptor Enphalitis
Date: 2015-09-23
Next >>>